Prenetics (PRE) Global announced a strategic partnership with Superpower. The partnership connects clinical-grade supplementation with comprehensive blood diagnostics, enabling an optimized testing loop to provide consumers with measurable proof behind supplement efficacy. M8 and Superpower are teaming up to address a fundamental gap within the wellness industry: most people who take supplements have no way to measure whether they’re working; meanwhile, most blood testing platforms surface hundreds of data points, but leave consumers to navigate a fragmented, low-quality supplement market on their own. Under the partnership, IM8 will integrate Superpower’s annual blood testing membership into the IM8 customer journey at exclusive pricing, while Superpower will integrate IM8’s Daily Ultimate Essentials into its personalized health protocols as a featured foundational nutritional ritual, available to all members on its supplement marketplace at a preferred rate.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRE:
- Prenetics initiated with a Buy at Lake Street
- Prenetics soars on IM8-fueled earnings call
- Prenetics Launches $40 Million Buyback as IM8 Growth, Liquidity Bolster Valuation Case
- Prenetics authorizes $40M share repurchase program
- Prenetics Executives Boost Personal Share Purchases to $2.75 Million After Earnings
